Navigation Links
Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
Date:1/11/2008

BOCA RATON, Fla., Jan. 11 /PRNewswire-USNewswire/ -- Florida Atlantic University and Scripps Florida will present the 2008 Distinguished Nobel Laureate Lecture on Wednesday, January 16 from 4-5:30 p.m. in the University Theatre, 777 Glades Road, Boca Raton. Gunter Blobel, M.D., Ph.D. is the 1999 recipient of the Nobel Prize in Physiology or Medicine and the John D. Rockefeller, Jr. Professor, The Rockefeller University, and Investigator, Howard Hughes Medical Institute. He will present a lecture entitled, "Nucleo-cytoplasmic Traffic," highlighting his groundbreaking research on the inner workings of the cell.

Blobel has spent years investigating and learning how proteins are delivered to their proper location to perform their specific function. He hypothesized and proved that each protein has a sequence in it -- a code -- which acts as a "zip code" directing the protein to the proper location or cellular address within the cell. Blobel's research is vital to helping understand what is wrong with cancer cells, what the AIDS virus or Alzheimer's disease does to cells, and how to develop drugs to combat these and other diseases.

"We are deeply honored to host Dr. Blobel at Florida Atlantic University and to be working in collaboration with The Scripps Research Institute and Scripps Florida to bring an event of this magnitude to South Florida," said FAU President Frank T. Brogan.

"Gunter Blobel is both a friend and a colleague of long standing who is helping to guide Scripps as a member of our Board of Scientific Governors," said Scripps Research Institute President Richard A. Lerner, M.D. "I am sure the friends of FAU and Scripps, and those interested in the best of biomedical science will find his lecture intriguing and enlightening."

FAU's associate dean for research and industrial relations in the Charles E. Schmidt College of Science, Dr. Ramaswamy Narayanan, is co-chairing the event with Dr. William R. Roush, professor of chemistry and associate dean of the Kellogg School of Science and Technology, The Scripps Research Institute.

The 2008 Distinguished Nobel Laureate Lecture is open to the public, and there is no charge to attend. RSVP is required. To reserve a seat or for more information, visit http://www.fau.edu/research or call 561-297-2010.

Sponsors of the 2008 Distinguished Nobel Laureate Lecture include Scripps Florida, Boca Raton Community Hospital, the University of Miami Miller School of Medicine, the law firm of Carey Rodriguez Greenberg Paul, Healthcare District of Palm Beach County, Holy Cross Hospital, Katholieke Universitiet Leuven, the law firm of Ruden McClosky, University MRI, Workforce Alliance, the Florida Bioinformatics Consortium at FAU, the Charles E. Schmidt College of Science, the Charles E. Schmidt College of Biomedical Science, the Barry Kaye College of Business, the Christine E. Lynn College of Nursing, the College of Engineering and Computer Science, the Dorothy F. Schmidt College of Arts & Letters, FAU Foundation, Harbor Branch Oceanographic Institute at FAU and the Lifelong Learning Society at FAU.

Florida Atlantic University opened its doors in 1964 as the fifth public university in Florida. Today, the University serves more than 26,000 undergraduate and graduate students on seven campuses strategically located along 150 miles of Florida's southeastern coastline. Building on its rich tradition as a teaching university, with a world-class faculty, FAU hosts ten colleges: College of Architecture, Urban & Public Affairs, Dorothy F. Schmidt College of Arts & Letters, the Charles E. Schmidt College of Biomedical Science, the Barry Kaye College of Business, the College of Education, the College of Engineering & Computer Science, the Harriet L. Wilkes Honors College, the Graduate College, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science.

The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Scripps Research is headquartered in La Jolla, California. It also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Currently operating from temporary facilities in Jupiter, Scripps Florida will move to its permanent campus in 2009.

Media Contact:

Gisele Galoustian, 561-297-2010, ggaloust@fau.edu

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Florida Atlantic University
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Nobel Prize-Winning Discovery
2. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
3. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
4. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
5. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
6. Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
9. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
10. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
11. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):